The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection, in a deal worth EUR 3.2 billion (US$3.7 billion). / read more /
Check out the PharmTech Europe Supplement on APIs,
Excipients, and Manufacturing,
includes the
CPhI Worldwide
Planning Guide.
This year’s awards attracted more than 250 entries, which included innovations in products and service offerings from across the bio/pharmaceutical supply chain and honored companies and individuals driving the industry forward. / read more /
Evonik sets new standard for enteric coatings:
EUDRAGIT® FL 30 D-55 is an advanced, new combination polymer solution for enteric coatings that integrates the respective benefits of two existing, well-accepted monographs. It is highly flexible, plasticizer-free, and can be sprayed with a smooth, fast and no-stick process. As a single product, preparation times can be reduced by up to 70%. Visit Evonik at AAPS (booth 2127) or email healthcare@evonik.com Learn more
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation to seek views on how legislations and procedures of the agency may need to be modified should there be a ‘no-deal’ Brexit scenario. / read more /
Congress approves bills with provisions important to FDA and industry, some of which reflect continuing concerns about drug pricing and transparency. / read more /
The companies signed a three-year clinical manufacturing agreement to manufacture GlaxoSmithKline’s specific peptide enhanced affinity receptor T-cell receptor therapy for United States, Canadian, and European clinical trials. / read more /
The US$7.3-million (EUR 6.3-million) investment includes an upgrade and expansion of the company's packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy. / read more /
Vetter's FOYA award-winning facility is an example of a flexible pharmaceutical and biopharmaceutical modular facility design that allows expansion of space without affecting existing operations. / read more /
In this three-part podcast series, Rob Thomas, principal consultant at Scientific Solutions, discusses the impetus behind his book, Measuring Elemental Impurities in Pharmaceuticals: A Practical Guide. / read more /
Nexera Mikros - New Micro-Flow LC-MS solution Shimadzu has released the Nexera Mikros, a micro flowrate-compatible liquid chromatograph mass spectrometer. The Nexera Mikros maintains the durability and operability of LC-MS systems while providing at least ten times more sensitivity. / Read more/
SMA MicroParticle ICSTM
VAI is pleased to announce the addition of the SMA MicroParticle ICS line of non-viable particle counters that utilize the latest innovation in particle counting technology, to our contamination control portfolio. / Read more/
This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.
